Robin Lavoie

Robin Lavoie is a seasoned professional in the biotechnology and pharmaceutical sectors with extensive experience in manufacturing and process sciences. Currently serving as Lead Process Sciences at Alnylam Pharmaceuticals since April 2020, Robin previously held the position of Senior Manufacturing Associate at Repligen Corporation and worked as a Manufacturing Senior Associate in the PVU/DNA Group at Moderna, contributing to the production of personal cancer vaccines. Robin's earlier roles include significant contributions in the Purification Group at Genzyme, where efforts were directed towards the manufacturing of the Thyrogen drug for thyroid cancer, as well as foundational work at Amgen in both the Purification Department and Media Preparation Group, supporting the production of the biologic drug Enbrel. Educational background includes studies at the Community College of Rhode Island.